Hannah Wentzel

620 total citations
5 papers, 230 citations indexed

About

Hannah Wentzel is a scholar working on Infectious Diseases, Neurology and General Health Professions. According to data from OpenAlex, Hannah Wentzel has authored 5 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Neurology and 1 paper in General Health Professions. Recurrent topics in Hannah Wentzel's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Hannah Wentzel is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Hannah Wentzel collaborates with scholars based in Iran, United Kingdom and Netherlands. Hannah Wentzel's co-authors include Shahin Merat, Andrew Hill, Jacob Levi, Bryony Simmons, Anna Garratt, Majid Saeedi, Anahita Sadeghı, Ali Asgari, Reza Alizadeh‐Navaei and Fatemeh Roozbeh and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy and Nicotine & Tobacco Research.

In The Last Decade

Hannah Wentzel

5 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannah Wentzel Iran	5	194	70	36	30	23	5	230
Anna Garratt United Kingdom	4	147 0.8×	48 0.7×	35 1.0×	21 0.7×	16 0.7×	5	363
Jiandan Qian China	4	284 1.5×	88 1.3×	33 0.9×	41 1.4×	20 0.9×	8	374
Weiyin Lin China	8	267 1.4×	110 1.6×	50 1.4×	29 1.0×	18 0.8×	16	358
Yujuan Guan China	8	230 1.2×	116 1.7×	68 1.9×	26 0.9×	50 2.2×	20	344
Forough Heidarzad Iran	6	130 0.7×	55 0.8×	47 1.3×	19 0.6×	14 0.6×	7	230
Guangming Xiao China	2	193 1.0×	91 1.3×	23 0.6×	26 0.9×	6 0.3×	3	231
Kawthar Mohamed Iran	7	166 0.9×	48 0.7×	23 0.6×	59 2.0×	9 0.4×	13	278
Chunyan Wen China	3	229 1.2×	105 1.5×	23 0.6×	26 0.9×	5 0.2×	5	271
Qin Mao China	2	211 1.1×	70 1.0×	34 0.9×	35 1.2×	4 0.2×	6	297

Countries citing papers authored by Hannah Wentzel

Since Specialization

Citations

This map shows the geographic impact of Hannah Wentzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Wentzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Wentzel more than expected).

Fields of papers citing papers by Hannah Wentzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Wentzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Wentzel. The network helps show where Hannah Wentzel may publish in the future.

Co-authorship network of co-authors of Hannah Wentzel

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Wentzel. A scholar is included among the top collaborators of Hannah Wentzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Wentzel. Hannah Wentzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Sadeghı, Anahita, Ali Asgari, Alireza Norouzi, et al.. (2020). Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial. Journal of Antimicrobial Chemotherapy. 75(11). 3379–3385. 84 indexed citations

2.

Moradi, Siavash, Farhang Babamahmoodi, Ahmad Alikhani, et al.. (2020). Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial. Journal of Antimicrobial Chemotherapy. 75(11). 3373–3378. 66 indexed citations

3.

Simmons, Bryony, Hannah Wentzel, Sara Mobarak, et al.. (2020). Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis. Journal of Antimicrobial Chemotherapy. 76(2). 286–291. 23 indexed citations

4.

Roozbeh, Fatemeh, Majid Saeedi, Reza Alizadeh‐Navaei, et al.. (2020). Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial. Journal of Antimicrobial Chemotherapy. 76(3). 753–757. 47 indexed citations

5.

Lingsma, Hester F., et al.. (2014). Does Government Supervision Improve Stop-Smoking Counseling in Midwifery Practices?. Nicotine & Tobacco Research. 17(5). 572–579. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact